Corrigendum to “Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways” [Neuropharmacol. (2021) 1, 197, 108738]
Shaimaa S. Ibrahim , Omar G. Abo Elseoud , Mohamed H. Mohamedy , Mohamed M. Amer , Youssef Y. Mohamed , Shehab A. Elmansy , Mohamed M. Kadry , Ahmed A. Attia , Ragy A. Fanous , Mahmoud S. Kamel , Youssef A. Solyman , Mazen S. Shehata , Mina Y. George
{"title":"Corrigendum to “Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways” [Neuropharmacol. (2021) 1, 197, 108738]","authors":"Shaimaa S. Ibrahim , Omar G. Abo Elseoud , Mohamed H. Mohamedy , Mohamed M. Amer , Youssef Y. Mohamed , Shehab A. Elmansy , Mohamed M. Kadry , Ahmed A. Attia , Ragy A. Fanous , Mahmoud S. Kamel , Youssef A. Solyman , Mazen S. Shehata , Mina Y. George","doi":"10.1016/j.neuropharm.2024.109989","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0028390824001588/pdfft?md5=d2b304b6d01775a0494829f8b0a38cae&pid=1-s2.0-S0028390824001588-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028390824001588","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
期刊介绍：
Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
